Investigating Dietary Supplements for the Treatment of Canine Idiopathic Epilepsy

Canine idiopathic epilepsy, defined as recurrent seizures with no identifiable underlying cause, is the most common medical neurologic disease in dogs.  

Twenty to thirty percent of affected dogs continue to experience seizures despite treatment with currently available anti-epileptic drugs (AEDs).  In addition, side effects from these drugs, such as increased appetite, sedation, restlessness, or anxiety, often decrease the quality of life for affected dogs and their owners. For these reasons and more, the AKC Canine Health Foundation (CHF) launched its Epilepsy Research Initiative in January 2017 to focus efforts on this devastating condition and improve the understanding of and treatment for epilepsy in dogs. 

Dietary Supplement Usage in Epileptic Dogs

As part of the Epilepsy Research Initiative, investigators at the Royal Veterinary College, University of London were awarded CHF Grant 02252: Investigating a Ketogenic Medium-Chain Triglyceride (MCT) Supplement for

... read more at: